No Picture
News

ACADIA Pharmaceuticals to Present Phase 2 CLARITY Results for Pimavanserin as an Adjunctive Treatment in Major Depressive Disorder at the 2019 American Psychiatric Association Annual Meeting

SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, today annou… […]

No Picture
News

Microbiota Restoration Takes the Podium at DDW 2019: Investigational Microbiota-Based Therapies for Recurrent C. diff Highlighted

ROSEVILLE, Minn.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Cdiff?src=hash" target="_blank"gt;#Cdifflt;/agt;–Rebiotix to present research data on current microbiome trials at DDW 2019 in San Diego, CA (May 18-21). […]